GLP-1 Drugs: Fighting Diabetes and Weight💊
In recent years, GLP-1 receptor agonists have transformed the treatment landscape for type 2 diabetes and obesity, blurring the line between metabolic disease management and weight-loss therapy.
What are GLP-1 Drugs?
GLP-1 drugs are a class of medications that mimic the action of glucagon-like peptide-1 (GLP-1), a hormone naturally produced in the intestines. These agents help manage blood glucose levels and promote weight loss in individuals with type 2 diabetes and obesity.
It plays a key role in glucose and appetite regulation by:
-
Stimulating insulin release (glucose-dependent)
-
Suppressing glucagon secretion
-
Slowing gastric emptying
-
Increasing satiety and reducing appetite
In people with type 2 diabetes, this GLP-1 response is impaired leading to poor glycemic control.
Common examples :
-
Semaglutide (Ozempic®, Wegovy®)
-
Liraglutide (Victoza®, Saxenda®)
-
Dulaglutide (Trulicity®)
-
Tirzepatide (dual GLP-1/GIP agonist – Mounjaro®)
How They Help in Diabetes ?
GLP-1 drugs improve blood sugar control by:
-
Enhancing insulin secretion only when glucose is high → lower risk of hypoglycemia
-
Reducing post-meal glucose spikes
-
Supporting beta-cell function
Why They Cause Weight Loss ?
Unlike traditional antidiabetic drugs, GLP-1 agonists act on the brain’s appetite centers, leading to:
-
Reduced hunger
-
Smaller portion sizes
-
Longer feeling of fullness
Do you think GLP-1 drugs will become first-line therapy for obesity in the future or should lifestyle intervention always come first
? Share your thoughts.
MBH/AB
